Luckshi Rajendran
Overview
Explore the profile of Luckshi Rajendran including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
45
Citations
436
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Magyar C, Rajendran L, Li Z, Banz V, Vogel A, OKane G, et al.
Lancet Gastroenterol Hepatol
. 2025 Feb;
10(4):350-368.
PMID: 39993401
Hepatocellular carcinoma arises in the setting of cirrhosis in most cases, requiring multidisciplinary input to define resectability. In this regard, more precise surgical management considers patient factors and anatomical states,...
2.
Li Z, Aliseda D, Jones O, Rajendran L, Magyar C, Grant R, et al.
JHEP Rep
. 2025 Feb;
7(3):101290.
PMID: 39980751
Background & Aims: Gemcitabine/cisplatin (GemCis) was the long-standing first-line treatment for advanced biliary tract cancers (BTCs). Following positive results from the TOPAZ-01 and KEYNOTE-966 trials, immune checkpoint inhibitors (ICIs) combined...
3.
Rajendran L, Sapisochin G
Hepatobiliary Surg Nutr
. 2025 Feb;
14(1):131-135.
PMID: 39925904
No abstract available.
4.
Yan M, Li Z, Claasen M, Santiago A, Rajendran L, Munoz-Schuffenegger P, et al.
Ann Surg Oncol
. 2024 Dec;
32(3):1771-1783.
PMID: 39692983
Introduction: Patients with advanced hepatocellular carcinoma (HCC) and macrovascular invasion (MVI) are recommended to receive systemic therapy according to guidelines. Stereotactic body radiotherapy (SBRT) and surgery are increasingly used in...
5.
Magyar C, Rajendran L, Babakhani S, Choi W, Li Z, Bucur R, et al.
Surgery
. 2024 Dec;
178():108924.
PMID: 39632224
Background: Postoperative acute kidney injury is associated with an increase in hospital length of stay and mortality. Intraoperative hemodynamics and fluid management may contribute to acute kidney injury. The aim...
6.
Yan M, Li Z, Claasen M, Santiago A, Rajendran L, Munoz-Schuffenegger P, et al.
Ann Surg Oncol
. 2024 Dec;
32(3):1841-1842.
PMID: 39627643
No abstract available.
7.
Choi W, Ivanics T, Rajendran L, Li Z, Gavira F, Jones O, et al.
Surgery
. 2024 Nov;
:108917.
PMID: 39609218
Background: Solitary hepatocellular carcinoma measuring ≤3 cm represents approximately 30% of hepatocellular carcinoma cases, yet treatment guidelines lack robust evidence. This study compares oncologic outcomes after ablation, liver resection, and...
8.
Rajendran L, Sapisochin G, Cattral M
Curr Opin Organ Transplant
. 2024 Nov;
30(1):12-20.
PMID: 39607024
Purpose Of Review: Despite technical and therapeutic advances, only 20-40% of patients with colorectal liver metastases (CRLM) have resectable disease. Historically, the remaining patients with unresectable, liver-only CRLM would receive...
9.
Magyar C, Perera S, Rajendran L, Li Z, Almugbel F, Feng S, et al.
Transplantation
. 2024 Nov;
PMID: 39531339
Background: Hepatocellular carcinoma (HCC) recurs after liver transplantation (LT) in ~17% of patients. We aimed to retrospectively compare the outcomes of patients treated with different tyrosine kinase inhibitors (TKIs) for...
10.
Matar A, Oppat K, Bennett F, Warren E, Wehrle C, Li Z, et al.
Ann Surg Oncol
. 2024 Oct;
32(1):456-457.
PMID: 39460817
No abstract available.